MaxCyte, Inc. (MXCT)

NASDAQ: MXCT · Real-Time Price · USD

0.6836

-0.0332 (-4.63%)

At close: Mar 27, 2026, 4:00 PM EDT

0.6800

-0.0036 (-0.53%)

After-hours: Mar 27, 2026, 6:42 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cell Engineering Technology	33.03M	38.63M	41.29M	44.26M	33.89M
Cell Engineering Technology Growth	-14.50%	-6.44%	-6.72%	30.59%	29.52%
Total	33.03M	38.63M	41.29M	44.26M	33.89M
Total Growth	-14.50%	-6.44%	-6.72%	30.59%	29.52%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	21.08M	25.77M	32.42M	44.26M	33.89M
United States Growth	-18.20%	-20.52%	-26.75%	30.59%	29.52%
Outside The United States	11.95M	12.86M	8.87M	-	-
Outside The United States Growth	-7.08%	45.00%	-	-	-
Total	33.03M	38.63M	41.29M	44.26M	33.89M
Total Growth	-14.50%	-6.44%	-6.72%	30.59%	29.52%

Source: S&P Global Market Intelligence.